Abstract
Membrane-bound pyrophosphatases (mPPases) regulate energy homeostasis in pathogenic protozoan parasites and lack human homologues, which makes them promising targets in e.g. malaria. Yet only few nonphosphorus inhibitors have been reported so far. Here, we explore an isoxazole fragment hit, leading to the discovery of small mPPase inhibitors with 6-10 mu M IC50 values in the Thermotoga maritima test system. Promisingly, the compounds retained activity against Plasmodium falciparum mPPase in membranes and inhibited parasite growth.
Original language | English |
---|---|
Journal | ACS Medicinal Chemistry Letters |
Volume | 11 |
Issue number | 4 |
Pages (from-to) | 605-610 |
Number of pages | 6 |
ISSN | 1948-5875 |
DOIs | |
Publication status | Published - 9 Apr 2020 |
MoE publication type | A1 Journal article-refereed |
Fields of Science
- ACIDOCALCISOMES
- BISPHOSPHONATES
- Membrane-bound pyrophosphatase
- PUMPING PYROPHOSPHATASES
- TARGET
- TRYPANOSOMA-BRUCEI
- drug design
- isoxazoles
- protozoan diseases
- 317 Pharmacy
Equipment
-
Viikki Metabolomics Unit (LS-RIA/ Metabo-HiLIFE)
Sipari, N. (Manager)
Faculty of Biological and Environmental SciencesFacility/equipment: Core Facility